Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis

NCT00401271 is registered in ClinicalTrials.gov with Otsuka Frankfurt Research Institute GmbH as lead sponsor.

NCT NCT00401271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00401271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis
Lead sponsor
Otsuka Frankfurt Research Institute GmbH
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
March 31, 2007
Enrollment
54
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis